Malignant struma ovarii: A case report and review of the literature

Journal of Endocrinological Investigation

Volumn 30, Issue 6, 2007, Pages 517-520

  Mattuci, M Letizia ^a   Dellera, A ^a   Guerriero, A ^a   Barbieri, F ^a   Minelli, L ^a   Furlani, L ^a  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

Malignant struma ovarii

Indexed keywords

CA 19-9 ANTIGEN; IODINE 131;

ADULT; ARTICLE; CASE REPORT; ECHOGRAPHY; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY CYST; OVARY TERATOMA; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; UTERUS BIOPSY;

EID: 34848826205     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03346337     Document Type: Article

References (12)

1. Osmanagaoglu M, Bozkaya H, Reis A. Malignant Struma ovarii: a case report and review of literature. Indian J Med Sci 2004, 58: 206-10.
2. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and hystologically malignant struma ovarii: a clinicopathologic stycly of 54 cases. Int J Gynecol Pathol 1993, 12: 333-43.
3. Makani S, Kim W, Gaba AR. Struma ovarii with a focus of papillary thyroid cancer: a case report and a review of literature. Gynecol Oncol 2004, 94: 835-9.
4. Matsuda K, Maehama T, Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001, 82: 575-7.
5. Checrallah A, Medlej R, Saadé C, Khayat G, Halaby G. Malignant struma ovarii: an unusual presentation. Thyroid 2001, 11: 889-92.
6. 131I theraphy. Gynecol Oncol 2003, 89: 543-8.
7. Carcinoma differenziato della tiroide linee guida SIE-AIMN-AIFM per il trattamento ed il follow-up. Anno 2004.
8. Links TP, van Tol KM, Jager PL, et al. Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 2005, 12: 273-80.
9. Giovanella L, Ceriani L, Ghelfo A, Keller F. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma. Clin Chem Lab Med 2005, 43: 843-7.
10. Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994, 35: 257-62.
11. Rose PG, Arafah B, Abdul-Karima F. Malignant struma ovarii: recurrence and response to treatment monitored by thyroglobulin levels. Gynecol Oncol 1998, 70: 425-7.
12. Steed H, Chapman W, Laframboise S. Endometriosis-associated ovarian cancer: a clinicopatologic rewiew. J Obstet Gynaeol Can 2004, 26: 709-15.